Oncimmune Holdings plc (AIM: ONC.L), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, today announces its distributor in Columbia, Valentech International LLC (“Valentech”), has obtained regulatory approval for the sale of EarlyCDT—Lung
April 2, 2019
· 2 min read